These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 17291852

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
    Eltonsy S, Forget A, Beauchesne MF, Blais L.
    J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 7. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study.
    Thomas M, von Ziegenweidt J, Lee AJ, Price D.
    J Allergy Clin Immunol; 2009 Jan; 123(1):116-121.e10. PubMed ID: 18986690
    [Abstract] [Full Text] [Related]

  • 8. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [Abstract] [Full Text] [Related]

  • 9. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 10. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
    Ni Chroinin M, Greenstone I, Lasserson TJ, Ducharme FM.
    Cochrane Database Syst Rev; 2009 Oct 07; 2009(4):CD005307. PubMed ID: 19821344
    [Abstract] [Full Text] [Related]

  • 11. [Impact of preventive treatment with long-acting beta(2)-adrenergic agonists and inhaled corticosteroids on the morbidity and mortality of severe asthma exacerbations in 1543 patients].
    Plaza V, Bellido-Casado J, Rodrigo GJ, Solarte I, Rodríguez-Trigo G, Sepúlveda R, Neffen H, Perpiñá M.
    Arch Bronconeumol; 2009 Nov 07; 45(11):545-9. PubMed ID: 19651467
    [Abstract] [Full Text] [Related]

  • 12. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK, Hartzema AG, Winterstein AG, Segal R, Lu X, Hendeles L.
    Value Health; 2015 Mar 07; 18(2):260-70. PubMed ID: 25773561
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children.
    Bisgaard H.
    Pediatr Pulmonol; 2003 Nov 07; 36(5):391-8. PubMed ID: 14520721
    [Abstract] [Full Text] [Related]

  • 14. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?
    Beasley R, Weatherall M, Shirtcliffe P, Hancox R, Reddel HK.
    J Allergy Clin Immunol; 2014 Jan 07; 133(1):39-41. PubMed ID: 24369798
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological strategies for self-management of asthma exacerbations.
    Reddel HK, Barnes DJ, Exacerbation Advisory Panel.
    Eur Respir J; 2006 Jul 07; 28(1):182-99. PubMed ID: 16816348
    [Abstract] [Full Text] [Related]

  • 16. Safety of long-acting beta2-agonists in the treatment of asthma.
    Cazzola M, Matera MG.
    Ther Adv Respir Dis; 2007 Oct 07; 1(1):35-46. PubMed ID: 19124346
    [Abstract] [Full Text] [Related]

  • 17. The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population.
    Wells KE, Peterson EL, Ahmedani BK, Severson RK, Gleason-Comstock J, Williams LK.
    J Allergy Clin Immunol; 2012 May 07; 129(5):1274-1279.e2. PubMed ID: 22281166
    [Abstract] [Full Text] [Related]

  • 18. The addition of long-acting beta-agonists to inhaled corticosteroids in asthma.
    Sears MR.
    Curr Opin Pulm Med; 2011 Jan 07; 17(1):23-8. PubMed ID: 21045700
    [Abstract] [Full Text] [Related]

  • 19. Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma.
    Ververeli K, Chipps B.
    Ann Allergy Asthma Immunol; 2004 May 07; 92(5):512-22. PubMed ID: 15191019
    [Abstract] [Full Text] [Related]

  • 20. Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma.
    Nelson HS, Carr W, Nathan R, Portnoy JM.
    Ann Allergy Asthma Immunol; 2009 Jan 07; 102(1):11-5. PubMed ID: 19205279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.